Stay updated on Filgotinib in Small Bowel Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in Small Bowel Crohn's Disease Clinical Trial page.

Latest updates to the Filgotinib in Small Bowel Crohn's Disease Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide NIH notice appears above the 403 error, announcing a website transition and a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2. The page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating an access restriction to view the content. This reflects a permissions issue rather than a content update on the trial page.SummaryDifference0.5%

- Check44 days agoChange DetectedThe page now returns a 403 Forbidden error, replacing the usual study record content with an access-block message. This indicates the record is temporarily unavailable rather than a content update.SummaryDifference19%

Stay in the know with updates to Filgotinib in Small Bowel Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in Small Bowel Crohn's Disease Clinical Trial page.